Retatrutide vs Ozempic Weight Loss: Trial Data, Approval and Cost
No Comments on Retatrutide vs Ozempic Weight Loss: Trial Data, Approval and Cost
28/10/2026
Retatrutide delivered 28.7% average weight loss in its first Phase 3 trial, nearly double the 14.9% that semaglutide achieved at the Wegovy dose, but Ozempic is the drug patients can actually get today. Both are injected once a week. Both cause nausea.…